Programme: Antiretroviral therapy (deadline - March 24th, 2022, 18:00, KYI time)

Collection of the commercial offers for the programme "Medicines for antiretroviral therapy of adults, adolescents and children" is suspended. 

According to the letter received from the State Institution "Public Health Center of the MOH of Ukraine'' (hereinafter - the PHC) dated 22.03.2022 and with regards to the actual martial law in Ukraine since February 24th, 2022, taking into account active hostilities and in order to release budget funds under the in several areas of public health, including "Medicines for antiretroviral therapy for adults, adolescents and children" and "Medicines for the treatment of tuberculosis", PHC held a series of negotiations with international organizations on the possibility to purchase these medicines and medical devices for the donor funds. As a result of the negotiations, full support from all the donors was received.

Taking into account all the abovementioned, SE "Medical Procurement of Ukraine '' suspends the collection of commercial offers until publication of any official information from the Ministry of Health of Ukraine in confirmation or refutation of these intentions. We will inform on the official position of the Ministry of Health on procurement in these areas as soon as such information is received.

Call for proposals

The Order of the Ministry of Health of Ukraine № 1723 from August 11th, 2021 (as amended) approved the nomenclature of medicines, medical devices and auxiliaries to them, including the direction "Medicines for antiretroviral therapy in adults, adolescents and children", which will be purchased for budget funds in 2022 year under the budget program 2301400 "Provision of medical measures of separate state programs and complex measures of program character".

The order of the Ministry of Health of Ukraine № 120 from January 19th, 2022 brought to the SE "Medical Procurement of Ukraine" the list of areas of prevention, diagnosis and treatment in 2022, including the abovementioned area.

According to sub-point 1 of point 1 of the Resolution of the Cabinet of Ministers of Ukraine № 169 from February 28th, 2022 procurement of medicines will be carried out without the use of procurement and simplified procurement procedures defined by the Law of Ukraine "On Public Procurement", according to the list and amounts approved by the order of the Ministry of Health of Ukraine № 434 from March 8th, 2022.

Based on the above, please provide commercial offers for the following medicines and the necessary documents listed below:

INN Release form Dosage Unit

Quantity

Abacavir oral solution 20 mg/ml ml

559 920 

Abacavir/Lamivudine tablets 600 mg/300 mg tablets

546 510 

Abacavir/Lamivudine dispersible tablets 60 mg/30 mg tablets

213 540 

Abacavir/Lamivudine/Dolutegravir tablets 600 mg/300 mg/50 mg tablets

1 286 700 

Atazanavir/Ritonavir tablets, capsules 300 mg/100 mg tablets, capsules

293 910 

Darunavir tablets 600 mg tablets

115 260 

Darunavir tablets 400 mg tablets

7 200 

Dolutegravir tablets 50 mg tablets

2 688 420 

Dolutegravir dispersible tablets 10 mg tablets

188 070 

Zidovudine oral solution 10 mg/ml, 50 mg/ml ml 797 400 
Zidovudine/Lamivudine tablets 300 mg/150 mg tablets 840 900 
Zidovudine/Lamivudine dispersible tablets 60 mg/30 mg tablets

116 460 

Efavirenz tablets, capsules 200 mg tablets, capsules

138 780 

Lamivudine tablets, capsules 150 mg tablets, capsules

101 760 

Lamivudine

oral solution 10 mg/ml, 50 mg/ml ml 921 400 

Lopinavir/Ritonavir

tablets 200 mg/50 mg tablets 1 710 960 

Lopinavir/Ritonavir

tablets 100 mg/25 mg tablets 357 120 

Lopinavir/Ritonavir

oral solution 80 mg/20 mg, 1 ml ml 392 580 
Nevirapine oral suspension 10 mg/ml, 50 mg/ml ml 88 900 
Raltegravir tablets 400 mg tablets

203 220 

Raltegravir chewable tablets 100 mg tablets

84 300 

Ritonavir tablets, capsules 100 mg tablets, capsules

183 210 

Tenofovir/Emtricitabine

tablets 300 mg/200 mg tablets 1 788 930 

Tenofovir/Lamivudine/Efavirenz

tablets 300 mg/300 mg/400 mg tablets 1 775 490 

Tenofovir/Lamivudine/Dolutegravir

tablets 300 mg/300 mg/50 mg tablets 33 829 500 

Tenofovir alafenamide/Emtricitabine/Dolutegravir

tablets 25 mg/200 mg/50 mg tablets 1 226 010 

It is worth noting that the commercial offer must contain the following information:

  • prices per unit in UAH, without VAT on the condition of DAP (Kyiv, Kyiv region, Ternopil, Ternopil region). In case of impossibility of delivery to the specified regions, please indicate possible places of delivery;
  • if the goods originate from the Republic of Belarus or the Russian Federation, please indicate this additionally.

Please provide the following documents in addition to the commercial offer:

For registered medicines:

  1. A copy of the current registration certificate for the medical product issued by the relevant authorized body in Ukraine. The documents are submitted by the bidder as part of the tender proposal, taking into account the requirements of current legislation of Ukraine, established before the registration of medical products that can be purchased by a person authorized to procure in the field of health care, including Art. 9, 9-1 of the Law of Ukraine "On Medical Products";
  2. A copy of the instructions for medical use in the state language or a copy of the instructions for use of the medical product in the state language;
  3. A copy of the valid document issued by the State Service of Ukraine for Medicines and Drug Control, confirming compliance with the conditions of production of the proposed medicines to the requirements for the production of medicines in Ukraine;
  4. A copy of the valid document issued by the WHO confirming the prequalification of the medical product and its authentic translation into the state (Ukrainian) language, or the participant may provide a printout from the electronic register of WHO prequalified medical product (with WHO Reference Number) with certified translation into Ukrainian,

AND/ OR

a copy of the current document confirming the approval / tentative approval of the medical product in the United States, the Swiss Confederation, Japan, Australia, Canada, Country – Member of the European Union or the competent body of the European Union in the original language (other than national), and their authentic translation into the state (Ukrainian) language.

For unregistered medicines:

  1. A copy of the valid document confirming the registration of the medical product by the competent authority of the country of Manufacturer/Applicant * or the United States of America, the Swiss Confederation, Japan, Australia, Canada, the Member States of the European Union.
  2. A copy of the valid document confirming the use of the medical product in the United States of America, the Swiss Confederation, Japan, Australia, Canada and/or in the territory of the Member States of the European Union (CoPP - Certificate of a Pharmaceutical Product (Certificate of Medical Product for International Trade)),

OR a copy of another valid document issued by the relevant body / institution / establishment in the field of health care from the list of countries defined in this paragraph, confirming the use of the medical product, 

OR a document (letter) issued by the State Enterprise «State Expert Center of the Ministry of Health of Ukraine», which certifies that based on the results of the examination of registration materials for such a medical product, conducted in the prescribed manner, the effectiveness, safety and quality of such a medical product are confirmed and such a medical product is recommended for registration.

  1. A copy of the instructions for use (other information on the use of the medical product) AND the summary of product characteristics ** approved in accordance with the regulatory requirements of the Applicant's country */Manufacturer or the United States, the Swiss Confederation, Japan, Australia, Canada, country members of the European Union according to the results of clinical trials, presented in the original language (language other than the state one), ALSO a translation of the instructions for use of the medicine (other information on the use of the medicine) and a summary of the product in the state (Ukrainian) language.
  2. A written commitment (in any form) of the Applicant */Manufacturer to register the medical product in Ukraine for its use in Ukraine before the delivery. 

In case where, during the registration of a medical product, there is a different Applicant than the Applicant* in the country where the medical product is registered, such a written commitment to register the medical product in Ukraine before delivery may be signed by the Applicant when registering the medical product in Ukraine subject to the submission of a power of attorney (POA) as part of the tender offer from the Manufacturer/Applicant*, confirming the authority to be the Applicant when registering a medical product in Ukraine.

  1. Copies of valid certificates of compliance with GMP requirements for production sites specified in the registration dossier, which are responsible for the release (certification) of a batch of finished medical product supplied (to be supplied) to Ukraine, presented in the original language (language other than the state one), and their authentic translation into the state (Ukrainian) language (if the certificate of compliance with the GMP requirements is included in the EudraGMP database or the US or Canadian FDA electronic register, the Participant may provide a printout of the EudraGMP database or the US FDA or Health Canada electronic register and their authentic translation into the state (Ukrainian) language.

OR 

a copy of the valid document issued by the State Service of Ukraine for Medical Products and Drug Control, which confirms the compliance of the conditions of production of the proposed medicines with the requirements for the production of medicines in Ukraine.

        6. A copy of the valid document issued by the WHO confirming the prequalification of the medical product and its authentic translation into the state (Ukrainian) language, or the participant may provide a printout from the electronic register of WHO prequalified medical product (with WHO Reference Number) with certified translation into Ukrainian,

AND/ OR

a copy of the current document confirming the approval / tentative approval of the medical product  in the United States, the Swiss Confederation, Japan, Australia, Canada, Country – Member of the European Union or the competent body of the European Union in the original language (other than national), and their authentic translation into the state (Ukrainian) language.

Given the limited time, we ask you to urgently send to the State Enterprise "Medical Procurement of Ukraine" until 18:00 of March 24th, 2022 to the e-mail address: This email address is being protected from spambots. You need JavaScript enabled to view it., a set of documents containing a commercial offer and the above information. If it is impossible to provide one of the documents, please specify this.

Please note that the provision of a price offer does not create any benefits for the market participant in procurement and does not impose any obligations on the State Enterprise "Medical Procurement of Ukraine" in relation to the market participant.

State Enterprise "Medical Procurement of Ukraine" 

+380 63 651 90 25

[email protected]

22 Khreshchatyk Str., 2nd floor, Kyiv, 01001

 

Subscribe

Each month we are sending our informational letter. Do not miss out!

Please fill the required field.
Please fill the required field.
© Copyright 2023 . Всі права захищено/ All rights reserved. Державне підприємство «Медичні закупівлі України»/ State Enterprise "Medical Procurement of Ukraine"